Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways

Phytother Res. 2009 Feb;23(2):262-6. doi: 10.1002/ptr.2606.

Abstract

Ginsenosides, the active component of ginseng, exerts antidiabetic and anticancer effects. This study investigated the molecular basis of ginsenoside Rg3, a red ginseng rich constituent, focusing on its ability to inhibit adipocyte differentiation in 3T3-L1 cells. The data show that ginsenoside Rg3 was effective in the inhibition of adipocyte differentiation. This inhibitory effect of ginsenoside Rg3 on adipocyte differentiation was accompanied by PPAR-gamma inhibition in rosiglitazone-treated cells. The study also tested whether AMP-activated protein kinase (AMPK) activation was involved in the inhibitory effects of ginsenoside Rg3. AMPK plays a role in maintaining health in the context of diseases such as type 2 diabetes, obesity and cancer. AMPK was reported to control nutritional and hormonal signal modulating. Rg3 significantly and time-dependently activated AMPK. Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, ginsenoside Rg3, involves the AMPK signaling pathway and PPAR-gamma inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • AMP-Activated Protein Kinases / metabolism*
  • Adipocytes / drug effects
  • Adipocytes / metabolism
  • Animals
  • Anti-Obesity Agents / pharmacology*
  • Cell Differentiation / drug effects*
  • Enzyme Activators / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Ginsenosides / pharmacology*
  • Mice
  • PPAR gamma / antagonists & inhibitors
  • PPAR gamma / metabolism*
  • Panax / chemistry*
  • Signal Transduction / drug effects

Substances

  • Anti-Obesity Agents
  • Enzyme Activators
  • Enzyme Inhibitors
  • Ginsenosides
  • PPAR gamma
  • ginsenoside Rg3
  • AMP-Activated Protein Kinases